| Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
|---|
| 01/16/2003 | WO2003004454A1 Linked cyclitols and their polysulfated derivatives |
| 01/16/2003 | WO2002046129A3 Inhibitors of histone deacetylase |
| 01/16/2003 | WO2002011715A3 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 01/16/2003 | US20030013897 1,2- methylenedioxy-benzene and glyoxylic acid are reacted to form 3, 4-methylenedioxymandelic acid in presence of a strong acid, solvent extraction, neuturalization with a base, separtion of organic and aqueous phase, oxidation with HNO3 |
| 01/16/2003 | US20030013887 Substituted aromatic ethers as inhibitors of glycine transport |
| 01/16/2003 | US20030013757 Aromatic dicarboxylic acid derivatives |
| 01/16/2003 | US20030013751 Viricides; enzyme inhibitors |
| 01/16/2003 | US20030013677 Anticancer agents |
| 01/16/2003 | US20030013100 Nucleic acid reading and analysis system |
| 01/15/2003 | EP0790989B1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
| 01/15/2003 | CN1391571A Heterocyclic compounds and their use as medicines |
| 01/15/2003 | CN1391469A Npyy5拮抗剂 Npyy5 antagonist |
| 01/15/2003 | CN1390831A Intermediate of anti-AIDS medicine 'Nelfinavir' and its syntesizing process and application |
| 01/14/2003 | US6506936 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production |
| 01/14/2003 | US6506876 LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use |
| 01/14/2003 | US6506793 For sustained release of lemon aroma unique to citral; perfumes; leucine dehydrogenase inhibitors; deodorants, cosmetics, dermatology agents |
| 01/14/2003 | US6506757 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| 01/14/2003 | US6506701 Polymer-supported quenching reagent covalently reacts with unreacted starting materials |
| 01/14/2003 | US6506558 Deprotecting nucleoside, nucleotide or amino acid to form polypeptide or polynucleotide |
| 01/14/2003 | CA2246758C Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii |
| 01/09/2003 | WO2003002550A1 Dioxalane derivatives and a process for their preparation |
| 01/09/2003 | WO2003002547A1 Process for the recovery of a polyol from an aqueous solution |
| 01/09/2003 | WO2003002519A1 Phenol derivatives and their use in medicaments |
| 01/09/2003 | WO2003002255A1 Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 01/09/2003 | WO2002059102A3 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use |
| 01/09/2003 | WO2001068637A3 Method for the preparation of tetrahydrobenzothiepines |
| 01/09/2003 | US20030008895 Prostaglandin agonists |
| 01/09/2003 | US20030008884 Fungicidal phenyl (thio) urea and phenyl (thio) carbamate derivatives |
| 01/09/2003 | US20030008876 Can mimic or block the effect of extracellular calcium on a cell surface calcium receptor; for use in therapy |
| 01/08/2003 | EP1272537A2 Ether-amine based polymerization catalysts, compositions and processes using same |
| 01/08/2003 | EP1272456A1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 01/08/2003 | EP1272176A1 Adamantyl derivatives as anti-cancer agents |
| 01/08/2003 | EP0996439B1 Beta-alkoxyacrylates against malaria |
| 01/08/2003 | CN1390196A Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 01/08/2003 | CN1389462A Grandifoliate burchellin and its homologue and application in preparing composite medicine |
| 01/07/2003 | US6504037 Reacting a cyclohexanedione or chromene-one derivative with 1,8-diazabicyclo(5.4.0)undec-7ene |
| 01/07/2003 | US6503949 Glucagon antagonists/inverse agonists |
| 01/07/2003 | US6503910 Hydroxamic and carboxylic acid derivatives |
| 01/03/2003 | WO2003000646A1 Substituted aromatic ethers as inhibitors of glycine transport |
| 01/03/2003 | WO2003000641A1 Integrated process for preparing dialkyl carbonates with a circulating catalyst |
| 01/03/2003 | CA2451673A1 Substituted aromatic ethers as inhibitors of glycine transport |
| 01/02/2003 | US20030004137 Muscle relaxants, controlling immunology, strokes, antidiabetic agents |
| 01/02/2003 | EP1270565A1 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives |
| 01/02/2003 | EP1270554A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| 01/02/2003 | EP1268492A1 Reactive monomers for the oligonucleotide and polynucleotide synthesis, modified oligonucleotides and polynucleotides, and a method for producing the same |
| 01/02/2003 | EP1268454A1 Succinoylamino heterocycles as inhibitors of a-beta protein production |
| 01/02/2003 | EP1268413A2 Substituted biphenyl derivatives |
| 01/02/2003 | EP1268401A1 Process for the selective n-formylation of n-hydroxylamines |
| 01/02/2003 | EP0891341B1 1,3,4-oxadiazine derivatives and their use as pesticides |
| 01/02/2003 | EP0630366B1 Substituted heterocyclic derivatives useful as platelet aggregation inhibitors |
| 01/01/2003 | CN1097602C Compounds with isocyanate group and closed & has reaction activation group to isocyanate group |
| 12/31/2002 | US6500964 By reacting substituted benzaldehyde(s) with alditol(s) such as sorbitol |
| 12/31/2002 | US6500832 Administering enzyme inhibitors as viricides for prophylaxis of viral diseases such as aquired immune deficiency syndrome |
| 12/31/2002 | US6500825 Substituted 2-aminoacetamides and the use thereof |
| 12/31/2002 | US6500812 Gastrointestinal disorders; antiinflammatory agents |
| 12/31/2002 | US6500213 Oxidizing hair coloring agents containing 2,5-diamino-1-phenylbenzene derivatives and novel 2,5-diamino-1-phenylbenzene derivatives |
| 12/27/2002 | WO2002102805A1 NEW USE Of CYCLOLIGNANS AND NEW CYCLOLIGNANS |
| 12/27/2002 | WO2002102804A1 New use of specific cyclolignans |
| 12/27/2002 | WO2002102803A1 Total synthesis of galanthamine, analogues and derivatives thereof |
| 12/27/2002 | WO2002102765A2 Protected tyrosine derivatives, method for the production thereof and use of the same for producing o-(2-[18f]-fluoroethyl)-l-tyrosine |
| 12/27/2002 | WO2002057227A8 Process of enantiomerically enriched flavor and fragrance components |
| 12/26/2002 | US20020198251 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 12/26/2002 | US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa |
| 12/26/2002 | US20020198188 A potent and safe inhibitors of mammalian cell proliferation for treating or preventing cancer, blood vessel proliferative disorders, fibrotic disorders and arteriosclerotic conditions |
| 12/26/2002 | US20020198184 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
| 12/25/2002 | CN1387507A Diaryl-enynes |
| 12/25/2002 | CN1097049C Processes for preparing intermediate product used in method of diastereoselective synthesis of nucleosides |
| 12/24/2002 | US6498190 Bicyclic amino derivatives and PGD2 antagonist containing the same |
| 12/24/2002 | US6498187 Fatty acid synthase inhibitors |
| 12/24/2002 | US6498172 Prostaglandin agonists and their use to treat bone disorders |
| 12/24/2002 | US6498168 Muscarinic antagonists |
| 12/24/2002 | US6498162 Treating inflammatory and allergic diseases of respiratory tract and diseases of central nervous system |
| 12/24/2002 | US6497730 Cationic methylenedioxy benzenes, their use for oxidation dyeing of keratin fibers, dyeing compositions and methods |
| 12/19/2002 | WO2002100813A2 Modulators of peroxisome proliferator activated receptors |
| 12/19/2002 | WO2002100812A1 Carboxylic acid derivative and salt thereof |
| 12/19/2002 | WO2002100392A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
| 12/19/2002 | WO2002100347A2 Prodrugs of gaba analogs, compositions and uses thereof |
| 12/19/2002 | WO2002070541A3 Peptide deformylase inhibitors |
| 12/19/2002 | US20020193622 For use as additives in chemical amplification photolithography, photoresists |
| 12/19/2002 | US20020193614 Treatment of cardiovascular disorders |
| 12/19/2002 | US20020193604 Aryl borates |
| 12/19/2002 | US20020193596 Inhibitors of protein isoprenyl transferases |
| 12/19/2002 | US20020193447 Chemical intermediates for bronchodilators |
| 12/19/2002 | US20020193354 7, 9-substituted tetracycline compounds |
| 12/19/2002 | US20020193291 Treating NIDDM with RXR agonists |
| 12/19/2002 | US20020192693 Apparatus for polymer synthesis |
| 12/19/2002 | US20020189033 Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same |
| 12/19/2002 | DE10127126A1 New protected O-(2-substituted ethyl)-L-tyrosine derivatives, useful as intermediates for the positron emission tomography contrast agent O-(2-(18F)-fluoroethyl)-L-tyrosine |
| 12/19/2002 | CA2449673A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
| 12/19/2002 | CA2449256A1 Modulators of peroxisome proliferator activated receptors |
| 12/18/2002 | EP1265890A1 Stereoselective synthesis of nucleoside analogues |
| 12/18/2002 | EP1265887A2 Carbocyclic side chain containing metalloprotease inhibitors |
| 12/18/2002 | EP1265886A2 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 12/18/2002 | EP1265857A1 Sulfonamide derivatives |
| 12/18/2002 | EP0843658B1 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
| 12/18/2002 | CN1096463C Procss for producing ecteinascidin and intermediate of said process |
| 12/18/2002 | CN1096457C Optically active tolane derivatives |
| 12/17/2002 | US6495725 Useful as chemical intermediates for prostaglandins and drugs |
| 12/17/2002 | US6495703 The present invention provides a simple and inexpensive process for preparing glycerol carbonate. namely, according to the present invention, glycerol carbonate is prepared by reacting glycerol with urea. |
| 12/17/2002 | US6495217 Chiral compounds |